Key result
Continuous wearable ECG monitoring proves feasible in high-risk adolescents with ~76% compliance.
Observational (n=121)
Continuous ambulatory HF-HRV monitoring via a chest-worn ECG is feasible in adolescents at high suicide risk, achieving high compliance and data quality over 2 to 3 weeks.
May support wearable HF-HRV monitoring in high-risk adolescents; hypothesis-generating for suicide risk applications, needing prospective trials.
Unlabelled: Continuous ambulatory HF-HRV (high-frequency heart rate variability) monitoring using a chest-worn ECG (electrocardiogram) device met a priori feasibility benchmarks (≥75% compliance and data quality) in adolescents at high risk for suicide over approximately two to three weeks, including during school days and sleep.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2026) conducted an observational in Depression and suicidality (n=121). Continuous ambulatory HF-HRV monitoring using a chest-worn ECG sensor was evaluated on Feasibility (compliance and data quality ≥75%). Continuous ambulatory HF-HRV monitoring using a chest-worn ECG sensor met a priori feasibility benchmarks with 76.21% compliance and 81.42% data quality in adolescents at high risk for suicide.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: